83/100 A · Moderate risk
No major risk flags in the public sources we cover Indicative TraceComp estimate from public sources — an automated indicator, not a credit decision, a completed due-diligence check, or a guarantee. Verify against the official register.

ℹ️ No matches surfaced in the limited public sources we cover (sanctions, screening, insolvency, control). This is an automated indicator — not an exhaustive check, a credit decision, or a guarantee, and absence of a match does not mean none exists. Verify against the official register.

Think this is wrong? This is an automated estimate — request a human review or correction.

OXYANE

Active Civil company / grouping 📍 Genas Active for 126 years

Civil company / grouping · Active since 1900

A

Overview

OXYANE is a civil company / grouping registered in Genas, France, since 1900. With reported revenue of 860.5M EUR in 2023. Its TraceComp score of 83 (A) indicates solid fundamentals and low apparent risk. With 126 years of operations, the company has an established track record in its market.

Company Information

Registration Number
775596885
Legal Form
Civil company / grouping
Registered
1900-01-01
Address
Genas

Financial Profile

Latest filed accounts: FY 2023 · most recent available in public filings

Revenue (2023) 860,483,000 EUR
Net Income
Total Assets 494,993,000 EUR
Altman Z 2.04 grey

Multi-year financials & ratios

5 years of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Risk Signals

No adverse legal events have been recorded for this company.

  • Revenue up 21% year-on-year

Similar Companies

Data Sources & Freshness

Data sourced from: official public registries.